SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-024001
Filing Date
2024-05-02
Accepted
2024-05-02 16:15:25
Documents
2
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1461
2 EXHIBIT 24 ef20028295_ex24.htm EX-24 7215
  Complete submission text file 0001140361-24-024001.txt   10196
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 BEAVER STREET C/O INTERLEUKIN GENETICS, INC. WALTHAM MA 02453
Business Address
Toutain Stephan (Reporting) CIK: 0001681658 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37568 | Film No.: 24908471